Toggle navigation
Browse
Home
Researchers
Research Departments
Publications
About/Support
BREAST CANCER RESEARCH AND TREATMENT
Journal
Overview
Research
Identity
Other
View All
Overview
publication venue for
Impact of body mass index on the efficacy of aromatase inhibitors in patients with metastatic breast cancer
. 192:313-319.
2022
Phase II trial of eribulin in patients who do not achieve pathologic complete response (pCR) following neoadjuvant chemotherapy
. 180:647-655.
2020
Research
category
ONCOLOGY
Web of Science Category
Identity
International Standard Serial Number (ISSN)
0167-6806
Electronic International Standard Serial Number (EISSN)
1573-7217
Other
journal abbreviation
BREAST CANCER RES TR